Ellipticines as DNA-Targeted Chemotherapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|5|575-591

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.5, 2014-01, pp. : 575-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment

By  

Current Medicinal Chemistry, Vol. 19, Iss. 25, 2012-09 ,pp. : 4218-4238

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Nanoparticle Based Targeted Delivery of Chemotherapeutics

By  

Current Bioactive Compounds, Vol. 5, Iss. 3, 2009-09 ,pp. : 170-184

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial:Tubulin-targeted Cancer Chemotherapeutics: Advances and Challenges

By  

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2522-2522

Bentham Science Publishers

Access to resources Recommend Favorite

Cytotoxic and DNA-targeted therapy in urothelial cancer: Have we squeezed the lemon enough?

By Balar Arjun V.   Milowsky Matthew I.  

Cancer, Vol. 121, Iss. 2, 2015-01 ,pp. : 179-187

Blackwell Publishing

Access to resources Recommend Favorite

Platinum-Intercalator Conjugates: From DNA-Targeted Cisplatin Derivatives to Adenine Binding Complexes as Potential Modulators of Gene Regulation

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 15, 2004-11 ,pp. : 1537-1549

Bentham Science Publishers

Access to resources Recommend Favorite